TL;DR. ADHD stimulants change skin through a small set of pathways: appetite suppression that reduces fluid and nutrient intake, increased sweating in some users, vascular constriction, and, for a subset of patients, increased skin picking. The skincare adjustments are small. The behavioral and medical pieces are bigger. This is not a reason to stop a medication that is helping you function.
Before anything else: ADHD stimulants are among the best-studied and most effective psychiatric medications in current use. If they are working for you, the skin side effects are almost always manageable around the medication, not by stopping it. Talk to your prescriber if anything in this article is bothering you. Don’t make a skincare decision a psychiatric one.
The patterns below come from the prescribing information, the dermatology literature, and the reader mail I get from people on Adderall, Vyvanse, Concerta, Ritalin, and the non-stimulant Strattera.
What is happening, by drug class
The stimulants split into two main families. Amphetamines (Adderall, Vyvanse, Dexedrine) and methylphenidate-based stimulants (Ritalin, Concerta, Focalin). Both increase dopamine and norepinephrine availability. The skin effects come from peripheral sympathetic activation: vasoconstriction, increased sweating in some users, reduced appetite, dry mouth, and sleep changes.
Non-stimulants include atomoxetine (Strattera), guanfacine (Intuniv), and viloxazine (Qelbree). Atomoxetine acts on norepinephrine and can cause dry mouth and reduced appetite similar to stimulants but with less pronounced cardiovascular effects. Guanfacine is an alpha-agonist that can produce skin coolness or paleness.
Why it happens, in plain language
The most consistent skin pattern on stimulants is dehydration. Not because the medication directly removes water from the skin, but because stimulants suppress thirst and appetite. People on Vyvanse routinely report drinking less water and forgetting to eat for hours. The skin reflects the deficit within days. Skin looks tight, lips chap, the undereye area looks slightly more hollow.
Sweating is the second pattern. Roughly 10 to 20 percent of stimulant users report increased sweating, often on the upper body and palms, peaking in the first two to four hours after the dose. The pattern can be heavier on extended-release formulations. Vasoconstriction produces a third pattern: cool skin, paler tone, occasionally Raynaud-type changes in fingertips.
The fourth pattern, and the one most often missed, is skin picking. ADHD itself is associated with elevated rates of dermatillomania. Stimulants can either reduce or increase the behavior depending on the user. For some people, stimulants quiet the impulse and picking stops. For others, particularly at higher doses, stimulants amplify the focused-attention loop and picking gets more intense. The skin shows it: persistent scabs in the same spots, small lesions that don’t heal because they keep being touched.
What helps
For dehydration: a humectant-rich routine, and the boring practice of drinking water on a schedule. Almost everyone on stimulants underestimates how dehydrated they are by midday. A water bottle on the desk that you refill three times before lunch will do more for your skin than any product. Microbiome Glow Serum paired with a glycerin-heavy moisturizer at night helps the skin retain what water it is getting.
For sweating: a fast morning routine without heavy occlusive products before the medication kicks in, and a cleanser for the chest and back at end of day to prevent folliculitis. For skin picking: the skincare matters least and the behavioral piece matters most. Habit-reversal training, CBT, and fidget tools that occupy the hands are the changes that matter. A barrier balm on healing lesions reduces friction that triggers picking on dry, flaky skin.
One general note: most people on stimulants are also poor about evening routines because they’re crashing from the medication. The honest fix is to do your evening routine in the late afternoon, before the wear-off, when you still have executive function. The 10 pm version of you cannot be relied on.
The contrarian take: stimulants aren’t the cause of your worst skin behavior
The pattern I see most often is a reader who started Vyvanse, within six months is picking more and breaking out more, and is ready to blame the medication. Some of this is the medication. Most of it is what the medication has revealed.
ADHD itself, before medication, often involves erratic eating, irregular sleep, and skin picking that wasn’t being addressed because it was happening in a fog of distraction. When the stimulant clears the fog, the underlying patterns become visible. The picking that was always there is now happening with more focus. The fix is to use the better resolution to do the work, not to turn the signal back off. A second contrarian note: the right intervention for skin picking is almost never a topical. It is therapy. The skincare around picking is supportive, not curative.
When to see a dermatologist
See a dermatologist for picking-related lesions that aren’t healing in two to three weeks, recurrent folliculitis on the chest or back, sudden severe acne in the first months of medication, persistent rashes that don’t respond to gentle care, or any skin finding involving significant scarring or infection. For the skin picking specifically, the most useful referral is often not a dermatologist but a therapist trained in body-focused repetitive behaviors. Ask your psychiatrist for a referral. The skin will follow.
The real numbers
The FDA prescribing information for lisdexamfetamine (Vyvanse) lists hyperhidrosis in approximately 4 percent of adult users and dry mouth in approximately 26 percent, compared to 1 percent and 3 percent on placebo respectively. For mixed amphetamine salts (Adderall XR), the rates are similar, with dry mouth approaching 35 percent at higher doses. A 2018 review in The Lancet Psychiatry summarized the comparative tolerability of ADHD medications across many studies and found dry mouth, appetite suppression, and sweating to be the most consistently reported skin-adjacent effects. Skin picking specifically has been studied less in randomized trials, with the strongest data coming from observational cohorts that estimate new-onset or worsened picking in roughly 10 percent of stimulant-treated adults in the first year.
For more, see our dehydration vs dryness explainer, adult acne protocol, and the adult acne tag hub.
FAQ
My skin looks duller since starting Vyvanse. Is that the medication? Often yes, indirectly. The dullness is usually a mix of dehydration and reduced sleep. Drink more water on a schedule and prioritize the evening wind-down. The dullness usually improves within a few weeks without product changes.
I pick my skin more on Adderall. Is that normal? It happens in roughly one in ten adult users, especially those with pre-existing skin-picking behaviors. Talk to your prescriber. A dose adjustment, a switch within the class, or addition of a non-stimulant can change the pattern. Behavioral therapy is also important and usually under-prescribed.
Does Strattera cause the same skin issues as stimulants? Some overlap, less intensity. Dry mouth and reduced appetite are present. Sweating is less common. The skin-picking effect is more variable in the literature.
Why do I break out on the weekends when I skip my medication? This is a real pattern. The medication suppresses appetite all week; the weekend brings binge-eating, dehydration breaks, and disrupted sleep, all of which trigger acne. The fix is more even eating across the week, not weekend medication.
Sources
Cortese S et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults. The Lancet Psychiatry, 2018. FDA. Lisdexamfetamine (Vyvanse) prescribing information, 2023 revision. Grant JE, Chamberlain SR. Trichotillomania and skin-picking disorder: an update. Focus: The Journal of Lifelong Learning in Psychiatry, 2016. American Academy of Pediatrics. Clinical practice guideline for the diagnosis, evaluation, and treatment of ADHD in children and adolescents, 2019.